D05.8

Clinical Causes: The exact causes of carcinoma in situ of the breast are not completely understood, but several risk factors have been associated with its development: - **Genetic predispositions:** Family history of breast cancer or genetic mutations like BRCA1 or BRCA2. - **Hormonal influences:** Prolonged exposure to estrogen, such as early menstruation or late menopause. - **Personal reproductive history:** Having children later or not at all, or never breastfeeding. - **Previous breast disease:** History of benign breast conditions or prior biopsies showing abnormal tissue. - **Environmental factors:** Exposure to radiation or carcinogenic substances. - **Age:** Increased risk with advancing age, particularly in women over 50. Understanding these factors may help in risk assessment, but they do not establish a direct cause-and-effect relationship. It is important to consult healthcare professionals for individualized risk evaluation.

Key Symptoms: Carcinoma in situ of the breast usually does not produce obvious symptoms and is often found incidentally during screening procedures. When symptoms do occur, they may include: - **Palpable lump:** A new or unusual lump in the breast tissue. - **Changes in breast appearance:** Unexplained thickening, redness, or puckering of the skin. - **Nipple changes:** Discharge (especially if bloody), inversion, or skin changes around the nipple. - **Persistent pain:** Although less common, some women may experience localized breast discomfort. It is important to note that many cases are asymptomatic, emphasizing the importance of routine screening for early detection.

Diagnosis Path: Diagnosis of carcinoma in situ of the breast generally involves a combination of clinical examinations and imaging studies: - **Mammography:** The primary screening tool that can identify suspicious calcifications or lesions. - **Ultrasound:** Complements mammography by characterizing the nature of suspicious areas. - **Biopsy:** The definitive method to confirm carcinoma in situ, involving the removal of tissue samples for microscopic examination. - **Histopathological analysis:** Determines the specific type and extent of the carcinoma in situ. Additional imaging, such as MRI, may be used in certain cases to evaluate the extent of the disease. Accurate diagnosis is crucial for planning appropriate treatment and management strategies.

Treatment Protocols: Treatment options for carcinoma in situ of the breast aim to eliminate abnormal cells and prevent progression to invasive cancer. Common approaches include: - **Surgical excision:** Removing the affected tissue, which may involve a lumpectomy (breast-conserving surgery) or on some occasions, mastectomy. - **Radiation therapy:** Often recommended after lumpectomy to reduce recurrence risk. - **Hormonal therapy:** In cases where the lesion is hormone receptor-positive, medications like tamoxifen may be prescribed. - **Active surveillance:** In selected cases, especially when lesions are small and low-risk, careful monitoring may be considered. Follow-up care involves regular screening and examinations to detect any recurrence or progression. Decisions regarding treatment depend on various factors, including lesion size, location, patient health, and preferences.